Additional instructions have been given to streamline the pharmaceutical sector

President Shavkat Mirziyoyev held a meeting on the regulation of the pharmaceutical sector, providing the population with high-quality and safe medicines.

The world is witnessing the growth of the pharmaceutical industry, new types and formulations of medicines are emerging. This necessitates constant quality control, detection and analysis of side effects.

On January 23, the President signed a decree “On additional measures to regulate the pharmaceutical industry.”

Thus, organizations that produce and sell medicines and medical devices are responsible for ensuring the quality and safety of their products. Special rules of state control will be established for them.

A system is being created aimed at promptly identifying and responding to threats related to the use of medicines. To do this, the standard "Good Practice of Pharmacological Supervision – GVP" will be introduced, and an electronic database on side effects of medicines will be created in the Ministry of Health. Prompt informing of medical workers and the public about such actions will be established.

Customs and free warehouses where medicines and medical supplies are stored will be gradually brought into line with the requirements of the rules of "Good Storage Practice – GSP". The Center of Good Practices at the Agency for the Development of the Pharmaceutical Industry is being reorganized into a state institution.

Advertising of drugs and biologically active additives on TV and radio channels will be allowed only on the basis of the conclusion of a special council to be established under the Ministry of Health.

The Head of our state, pointing out the importance of regulating the industry for the health of the population and the economy, gave additional instructions on the organization of effective execution of the decree.